Pancreatology

Papers
(The H4-Index of Pancreatology is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Letter to the Editor regarding ‘Prevalence and risk factors of fatigue and its association with quality of life among patients with chronic pancreatitis: A cross-sectional study.’276
CFTR correction, as a new therapeutic option in the treatment of chronic pancreatitis63
Hereditary pancreatitis - report of 73 paediatric patients42
Endosonography in the diagnosis and treatment of acute peripancreatic fluid collections37
Radon exposure and risk of pancreatic cancer in an area with high levels of radon35
Efficacy of endotherapy in the treatment of painful chronic pancreatitis : Predictors of response and impact on exocrine and endocrine insufficiency34
ERAP2 is a novel target involved in autophagy and activation of pancreatic stellate cells via UPR signaling pathway33
Intraoperative Gram staining of bile protocol to prevent infectious complications in pancreaticoduodenectomy29
Prognostic impact of osteosarcopenia in patients with advanced pancreatic cancer receiving gemcitabine plus nab-paclitaxel28
Impact of targeted SHP2-inhibition +/- MAPK-Inhibition on metabolic rewiring in pancreatic cancer28
Results of the first investigation about the understanding and engagement at time of diagnosis of patients with pancreatic cancer: the Communi.CARE study26
Fatty pancreas is a risk factor for pancreatic cancer: a systematic review and meta-analysis of 2956 patients26
Factors affecting prognosis after pancreatectomies for pancreatic cancer: a multivariate analysis26
Pharmacotyping, response prediction and tumour evolution in pancreatic cancer organoids26
Invalidity of Tokyo criteria for cholangitis and cholecystitis in acute biliary pancreatitis: An international cohort analysis of pancreatitis patients24
Very early recurrecnce after R0∖∖R1 resection for pancreatic ductal adenocarcinoma: Proof of concept for a Уbiological R2Ф definition24
The mechanism of Neuropeptide Y mediated nerve-cancer crosstalk.24
Pro-inflammatory cytokines of the IL-6 family induce regulatory T-cells and determine the severity of acute pancreatitis23
Hepatoid tumors of the pancreas harboring CTNNB1 somatic mutations: a new entity among solid pseudopapillary neoplasms.23
Cathepsin B inhibition in the pancreatic stellate cells stimulates CD8+ T cell dependent anti-tumor immune response23
Exploring the Neandertal legacy of pancreatic ductal adenocarcinoma risk in Eurasians22
Safe and effective protocol to discharge patients in acute pancreatitis22
Retrospective study of surgical patients with pancreatic neuroendocrine tumours (pNETs) in a Hepato-pancreato-biliary (HPB) surgical unit22
Determining the role of Serpin E1/PAI-1 in the development and progression of chronic pancreatitis22
Combination of novel biomarkers using liquid biopsy and imaging techniques as a more accurate tool for early detection of exocrine pancreatic cancer in high-risk populations22
Biological role of acid sphingomyelinase for pancreatic carcinogenesis22
0.17759203910828